|Year : 2019 | Volume
| Issue : 4 | Page : 447-452
Cloves syndrome: A rare disorder of overgrowth with unusual features – An uncommon phenotype?
Vikram K Mahajan, Mrinal Gupta, Pushpinder Chauhan, Karaninder S Mehta
Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Kangra, (Tanda), Himachal Pradesh, India
|Date of Web Publication||28-Jun-2019|
Vikram K Mahajan
Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Kangra, (Tanda) - 176 001, Himachal Pradesh
Source of Support: None, Conflict of Interest: None
| Abstract|| |
CLOVES syndrome characterized by Congenital Lipomatous Overgrowth, Vascular malformations, Epidermal nevi, and Skeletal anomalies is a recently described sporadic syndrome from postzygotic activating mutations in PIK3CA. This 3-year-old boy, born to nonconsanguineous and healthy parents, had epidermal verrucous nevus, lower limb length discrepancy and bilateral genuvalgum, anterior abdominal wall lipomatous mass, central beaking of L2 and L3, and fibrous dysplasia of the left frontal bone. Ocular and dental abnormalities (ptosis, esotropia, delayed canine eruption, dental hypoplasia), ipsilateral asymmetrical deformity of skull, and large left cerebral hemisphere with mild ipsilateral ventriculomegaly were peculiar to him denoting an uncommon phenotype. The parents did not consent for magnetic resonance imaging and genetic studies because of financial constraints. The CLOVES syndrome has emerged as an uncommon yet distinct clinical entity with some phenotypic variations. Its diagnosis is usually from cutaneous, truncal, spinal, and foot anomalies in clinical and radioimaging studies. Proteus syndrome remains the major differential.
Keywords: Congenital asymmetric overgrowth, congenital lipomatous hamartoma, lipoma, lymphovascular malformation, PIK3CA-related overgrowth spectrum, Proteus syndrome
|How to cite this article:|
Mahajan VK, Gupta M, Chauhan P, Mehta KS. Cloves syndrome: A rare disorder of overgrowth with unusual features – An uncommon phenotype?. Indian Dermatol Online J 2019;10:447-52
|How to cite this URL:|
Mahajan VK, Gupta M, Chauhan P, Mehta KS. Cloves syndrome: A rare disorder of overgrowth with unusual features – An uncommon phenotype?. Indian Dermatol Online J [serial online] 2019 [cited 2020 Jun 6];10:447-52. Available from: http://www.idoj.in/text.asp?2019/10/4/447/261803
| Introduction|| |
CLOVE (S) syndrome is a recently described overgrowth syndrome, and the acronym CLOVES includes a constellation of Congenital Lipomatous Overgrowth due to dysregulated adipose tissue, Vascular malformations (typically truncal), Epidermal nevi, and Scoliosis and/or Skeletal abnormalities such as enlarged bony structure (typically of the legs) without progressive or distorting bony overgrowth., The venous malformations as superficial phlebectasia and capillary malformations are present in association with lipomatous masses in truncal regions and may or may not accompany skeletal overgrowth when involving extremities. Central nervous system (CNS) manifestations include polymicrogyria, noncontiguous abnormalities of the gray and white matter, a four-layered cortex, ventriculomegaly, hemimegalencephaly, dysgenesis of the corpus callosum, neuronal migration defects and consequent seizures, tethered spinal cord, and neural tube defects., Some degree of neuorologic impairment has been reported in almost 50% cases in a large series. Visceral anomalies occur in the form of renal agenesis/hypoplasia, Wilms tumor, splenic lesions, and extensive deep retroperitoneal and pelvic fatty and lymphatic malformation.,, However, no intellectual, cardiovascular, gastrointestinal, or hematopoietic abnormalities have been attributed to CLOVES syndrome. The deformities are present at birth, and most acral deformities, often symmetrical, increase with growth but are not rapidly progressive. The pathogenesis of CLOVES syndrome has been attributed to somatic (postzygotic) mutations in PIK3CA gene mapped to chromosome 3q26.32. The PIK3CA gene is an upstream regulator of the Akt-mTOR cell signaling pathway and its activation mutations and of Akt cell signalling axis is in the form of cell proliferation and resultant lymphatic and other vascular malformation/overgrowth syndromes clubbed under PIK3CA-related overgrowth spectrum (PROS). We report a case of extremely rare CLOVES syndrome of which only fewer than 150 cases have been reported worldwide.
| Case Report|| |
This 3-year-old boy had pigmented skin lesions over left half of the body since birth, skull deformity, and progressive enlarging abdomen. He was the first child born after an uneventful gestation/pregnancy to otherwise healthy, nonconsanguineous parents. His family and medical history was unremarkable. The child had normal growth and mental development milestones and was immunized for his age. The child was playful and showed a linear verrucous epidermal nevus over the left side of the body extending from the neck, axilla and arm, dorsum of the hand, and anterior surface of the thigh [Figure 1]a and [Figure 1]b. He had an asymmetrical deformity of the left side of the head, ptosis and esotropia [Figure 1]c, and an ipsilateral abdominal wall mass of soft consistency [Figure 1]d. He had bilateral genu valgum, and his left lower limb was longer by 2 cm than the right one but showed no deformity of hands and feet. He had delayed canine eruption and dental hypoplasia. A fine needle aspiration cytology from abdominal wall mass showed features consistent with lipoma. Spine X-rays revealed central beaking of L2 and L3 vertebrae. Ultrasonography (USG) and computed tomography (CT) of abdomen showed lipomatous mass of the anterior abdominal wall and no visceral anomaly [Figure 2]a. USG Doppler of the anterior abdominal wall mass showed no vascular malformation. CT of head showed ground glass appearance (probable fibrous dysplasia) of the left frontal bone [Figure 2]b and large volume (megalencephaly) of the left cerebral hemisphere [Figure 2]c with mild ipsilateral ventriculomegaly [Figure 2]d. However, due to affordability concerns, the parents did not consent for biopsy, magnetic resonance imaging (MRI), and genetic studies. They were counseled about the nature of disorder but did not turn up for follow-up.
|Figure 1: (a) Verrucous epidermal nevus over left side of neck. (b) Verrucous epidermal nevus extending over left axilla and arm. Similar lesions were also present over dorsum of left hand and anterior left thigh. (c) Left ptosis and asymmetric skull. (d) Lipomatous mass of anterior abdominal wall. No overlying phlebectasia is seen|
Click here to view
|Figure 2: (a) Anterior abdominal wall lipomatous mass in computed tomography abdomen. (b) Fibrous dysplasia (?) of left frontal bone in computed tomography head. (c) Large cerebral volume of left cerebral hemisphere in computed tomography brain. (d) Left ventriculomegaly in computed tomography brain|
Click here to view
| Discussion|| |
Except for obvious vascular and hands/feet anomalies, this child displayed characteristic features of a parietal wall lipomatous mass, linear epidermal nevus, limb length discrepancy, and CNS anomalies suggestive of CLOVES syndrome. A review of cases suggests that the deformities are present prenatally, at birth or puberty in a few and get accentuated with growth. The major deformities invariably include deposition of adipose tissue in all body regions and tissue spaces including face, scrotum, paraspinal musculature, epidural spaces, mediastinum, and pleura. The prominent upper limb deformities include symmetrical overgrowth of digit(s), laxity of collateral ligaments of metacarpophalangeal and interphalangeal joints, and broad spade like hands with ulnar deviation of digits., Whereas the lower limbs show soft tissue overgrowth of feet and broad forefoot, large bulbous toes, wide first toe web (sandal gap), plantar creases, lipomatous masses on plantar and dorsal feet, and wide gaps between metatarsal heads in 50% of 18 cases reviewed.,,, All patients show lymphatic, venous and capillary (low-flow), or arteriovenous malformations (port-wine stains) with or without arteriovenous fistulae (high-flow vascular anomalies) that usually become evident during childhood., Various venous, lymphatic lymphaticovenous, and fast-flow vascular anomalies alone or adjacent to lipomatous masses or a cutaneous birthmark are most common and seen over trunk (spinal-paraspinal) and limbs, whereas lymphatic and venous malformation can involve all the affected regions. No cutaneous vascular anomaly was observed in our patient, and it is possible that deep vascular malformations in our patient remained unidentified for want of MRI studies. However, it is distinctly possible that some patients rather than all the signs have a combination of anomalies that may be subtle and do not manifest simultaneously but develop as the syndrome evolves., Although strabismus consequent from overgrowth of face and premature growth of teeth abnormalities can occur, auditory anomalies remain unreported.,, Interestingly, ocular and dental abnormalities (ptosis, esotropia, delayed canine eruption, dental hypoplasia), ipsilateral asymmetrical deformity of skull, and large left cerebral hemisphere with mild ipsilateral ventriculomegaly in our patient were peculiar and perhaps denote an uncommon phenotype. However, it remains conjectural for now for paucity of cases and can be resolved after long-term follow-up of such cases in view of variable and broad phenotypic spectrum of the disorder in general.
The diagnosis of CLOVES syndrome remains clinical from cutaneous, vascular, truncal, spinal, and limb anomalies and needs differentiation particularly from Proteus syndrome. However, the differentiation made on the basis of lack of visceral involvement and skeletal overgrowth being gradual in increasing volume of the affected soft tissues in CLOVES syndrome referred as “ballooning” overgrowth compared with involvement and rapidly deforming and “distorting” bony overgrowth that is relentlessly progressive and out of proportion to somatic growth in Proteus syndrome remains contested., While demonstrating mosaic activation mutation of PIK3CA gene in affected tissue samples, urine, or tumor cells is essential for confirmation of clinical diagnosis or differentiating PIK3CA gene mutation-associated lymphatic and other vascular malformation/overgrowth syndromes or PROS with many overlapping clinical features [Table 1],,, we considered the diagnosis of CLOVES syndrome in our patient based on diagnostic criteria by Keppler-Noreuil et al. [Table 2].
|Table 1: Common differentials of overgrowth syndromes with overlapping features|
Click here to view
A detailed clinical examination and radioimaging studies such as skeletal X-rays, USG abdomen, Doppler USG, cranial and spinal X-rays, CT, and MRI are imperative for delineating the extent of deformities, their management, and assessing long-term prognosis.,, However, severe scoliosis, large truncal mass, paraspinal high-flow lesions with spinal cord ischemia, lymphatic malformations, cutaneous vascular malformations, orthopedic problems of feet and hands, and central phlebectasia/thromboembolism in CLOVES syndrome need active or prophylactic surgical/medical interventions to improve quality of life. This will also prevent cutaneous and visceral morbidities, neurological deficit, pain, breathing difficulties, and possible complications such as hemoptysis, gastrointestinal bleeding or obstruction, and pulmonary embolism arising from vascular anomalies.,,, mTOR inhibitors (sirolimus), PI3K inhibitors (copanlisib and other isoforms), and BYL719 in the treatment of complicated vascular or other overgrowth anomalies in experimental and early clinical trials appear attractive therapeutic possibilities.,, However, excessive scarring after surgery in these individuals remains a concern. This syndrome can also be detected during the prenatal period from the presence of truncal mass and other body and acral anomalies and mosaic PIK3CA mutation in cultured amniocytes. Overall, the nonprogressive distorting nature of CLOVES syndrome can be explained while counseling the parents.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Sapp JC, Turner JT, van de Kamp JM, van Dijk FS, Brian Lowry R, Biesecker LG. Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients. Am J Med Genet 2007;143A:2944-58.
Alomari AI. CLOVE(S) syndrome: Expanding the acronym. Am J Med Genet A 2009;149A: 294.
Bloom J, Upton J. CLOVES syndrome. J Hand Surg Am 2013;38:2508-12.
Gucev ZS, Tasic V, Jancevska A, Konstantinova MK, Pop-Jordanova N, Trajkovski Z, et al.
CLOVE syndrome (Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi): CNS malformations and seizures may be a component of this disorder. Am J Med Genet A 2008;146A: 2688-90.
Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and sacral anomalies: A descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol2009;18:1-7.
Alomari AI, Chaudry G, Rodesch G, Burrows PE, Mulliken JB, Smith ER, et al.
Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: Analysis of clinical and imaging findings in 6 patients. AJNR Am J Neuroradiol 2011;3:1812-7.
Alomari AI. Comments on the diagnosis and management of CLOVES syndrome. Pediatr Dermatol 2011;28:215-6.
Kurek KC, Luks VL, Ayturk UM, Alomari AI, Fishman SJ, Spencer SA, et al.
Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet2012;90:1108-15.
Anderson S, Brooks SS. An extremely rare disorder of somatic mosaicism: CLOVES syndrome. Adv Neonatal Care 2016;16:347-59.
Klein S, Stroberg A, Ghahremani S, Martinez-Agosto JA. Phenotypic progression of skeletal anomalies in CLOVES syndrome. Am J Med Genet Part A 2012;158A:1690-5.
Mirastschijski U, Altmann S, Lenz-Scharf O, Muschke P, Schneider W. Syndromes with focal overgrowth in infancy: Diagnostic approach and surgical treatment. J Plast Surg Hand Surg 2012;46:45-8.
Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, Parker VER, Blumhorst C, Darling D, et al.
Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A 2014;164A:1713-33.
Martinez-Lopez A, Blasco-Morente G, Perez-Lopez I, Herrera-Garcia JD, Luque-Valenzuela M, Sanchez-Cano D, et al.
CLOVES syndrome: Review of a PIK3CA-related overgrowth spectrum (PROS). Clin Genet 2017:;91:14-21.
Luks VL, Kamitaki N, Vivero MP, Uller W, Rab R, Bovée JV, et al.
Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 2015;166:1048-54.
Keppler-Noreuil KM, Rios JJ, Parker VE, Semple RK, Lindhurst MJ, Sapp JC, et al.
PIK3CA-related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A2015;167A: 287-95.
Kuentz P, St-Onge J, Duffourd Y, Courcet JB, Carmignac V, Jouan T, et al.
Molecular diagnosis of PIK3CA
-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing. Genet Med 2017;19:989-97.
Michel ME, Konczyk DJ, Yeung KS, Murillo R, Vivero MP, Hall AM, et al.
Causal somatic mutations in urine DNA from persons with the CLOVES subgroup of the PIK3CA Related Overgrowth Spectrum (PROS). Clin Genet 2018;93:1075-80.
Alomari AI, Burrows PE, Lee EY, Hedequist DJ, Mulliken JB, Fishman SJ. CLOVES syndrome with thoracic and central phlebectasia: Increased risk of pulmonary embolism. J Thorac Cardiovasc Surg 2010;140:459-63.
Adams DM, Trenor CC III, Hammill AM, Vinks AA, Patel MN, Chaudry G, et al.
Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 2016;137:e20153257.
Keppler-Noreuil KM, Parker VER, Darling TN, Martinez-Agosto JA. Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies. Am J Med Genet C Semin Med Genet 2016;172:402-21.
Venot Q, Thomas Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, et al.
Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 2018;558:540-6.
Steiner JE, Cottrell CE, Streicher JL, Jensen JN, King DM, Burrows PE, et al.
Scarring in patients with PIK3CA-related overgrowth syndromes. JAMA Dermatol 2018;154:452-5.
Emrick LT, Murphy L, Shamshirsaz AA, Ruano R, Cassady CI, Liu L, et al.
Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes. Am J Med Genet A 2014;164A:2633-7.
[Figure 1], [Figure 2]
[Table 1], [Table 2]